HPV-18 transformed cells fail to arrest in G1 in response to quercetin treatment

Article English OPEN
Beniston, R.G. ; Campo, M.S. (2005)
  • Publisher: Elsevier Science
  • Related identifiers: doi: 10.1016/j.virusres.2004.12.002
  • Subject: SF600 | QR180
    mesheuropmc: heterocyclic compounds | female genital diseases and pregnancy complications

Previous work with primary human keratinocytes demonstrated that quercetin, a potent mutagen found in high levels in bracken fern (Pteridium aquilinum), arrested cells in G1 with concomitant elevation of the cyclin-dependent kinase inhibitor (cdki) p27Kip1. Expression of the human papillomavirus type 16 (HPV-16) E6 and E7 oncoproteins, under transcriptional control of a heterologous promoter, in transformed keratinocytes failed to abrogate this arrest [Beniston, R., Campo, M.S., 2003. Quercetin elevates p27(Kip1) and arrests both primary and HPV-16 E6/E7 transformed human keratinocytes in G1. Oncogene 22, 5504–5514]. Given the link between papillomavirus infection, bracken fern in the diet and cancer of the oesophagus in humans, we wished to investigate further whether cells transformed by the whole genome of HPV-16 or HPV-18, with E6 and E7 under the transcriptional control of their respective homologous promoters, would be similarly arrested in G1 by quercetin. In agreement with earlier work, quercetin arrested HPV-16 transformed cells in G1 with an increase in the cyclin-dependent kinase inhibitor p27Kip1. However, HPV-18 transformed cells did not arrest after quercetin treatment. The failure of HPV-18 transformed cells to arrest in G1 was linked to the up-regulation of the HPV-18 long control region (LCR) by quercetin, maintaining high expression of the viral transforming proteins. Transcriptional up-regulation of the HPV-18 LCR was mediated by a “quercetin responsive element” homologous to the one identified previously in the bovine papillomavirus type 4 (BPV-4) LCR.
  • References (20)
    20 references, page 1 of 2

    Alonso-Amelot, M.E., Castillo, U., Smith, B.L., Lauren, D.R., 1996. Bracken ptaquiloside in milk. Nature 382, 587.

    Beniston, R., Campo, M.S., 2003. Quercetin elevates p27(Kip1) and arrests both primary and HPV-16 E6/E7 transformed human keratinocytes in G1. Oncogene 22, 5504- 5514.

    Beniston, R.G., Morgan, I.M., O'Brien, V., Campo, M.S., 2001. Quercetin, E7 and p53 in papillomavirus oncogenic cell transformation. Carcinogenesis 22, 1069-1076.

    Bjeldanes, LF., Chang, G.W., 1977. Mutagenic activity of quercetin and related compounds. Science 197, 577-578.

    Cairney, M., Campo, M.S., 1995. The synergism between bovine papillomavirus type 4 and quercetin is dependent on the timing of exposure. Carcinogenesis 16, 1997-2001.

    Campo, M.S., O'Neil, B.W., Barron, R.J., Jarrett, W.F., 1994. Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis 15, 1597-1601.

    Chang, F., Syrjanen, S., Shen, Q., Ji, H.X., Syrjanen, K., 1990. Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Int. J. Cancer 45, 21-25.

    Connolly, J.A., Morgan, I.M., Jackson, M.E., Campo, M.S., 1998. The BPV-4 co-carcinogen quercetin induces cell cycle arrest and up-regulates transcription from the LCR of BPV-4. Oncogene 16, 2739-2746.

    Cooper, K., Taylor, L., Govind, S., 1995. Human papillomavirus DNA in oesophageal carcinomas in South Africa. J. Pathol. 175, 273-277.

    Davies, S.P., Reddy, H., Caivano, M., Cohen, P., 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.

  • Similar Research Results (3)
  • Metrics
    No metrics available
Share - Bookmark